Pharmaceutical
Oxford Cannabinoid Technologies Signs New Agreement With Stemtech
OCT believes Stemtech’s technology provides an in vitro translational model that will better predict results in humans.
Dr John Lucas
1story
17 Novlast updated
Tuesday, 3 November 2026
Sections
Data & Trackers
What’s On
- Every event across the PP group
- BofC Awards 2026
- Business of Cannabis New York 2026
- European Cannabis Insights Summit 2026
- All events coverage